Darolutamide

Spécifications

1297538-32-9Numéro CAS

829-313-8Numéro CE

N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamideNom IUPAC

C19H19ClN6O2Formule chimique

398.8 g/molMasse molaire

Darolutamide; 1297538-32-9; ODM-201; Nubeqa; BAY1841788; BAY-1841788; darolutamida; X05U0N2RCO; BAY 1841788; 1H-Pyrazole-3-carboxamide, N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-; DTXSID101027953; N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; 1H-Pyrazole-3-carboxamide, N-((1S)-2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-; N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((1RS)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide; darolutamidum; N-((1S)-2-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-1-methylethyl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; N-((2S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; N-((2S)-1-(3-(3-chloro-4-cyanophenyl)pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; Antiandrogen ODM-201; RefChem:58141; L02BB06; DTXCID001513521; N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; Darolutamide (ODM-201); MFCD29472270; Darolutamide [USAN]; ODM-201;BAY-1841788; N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide; N-[(1S)-2-[3-(3-chloro-4-cyano-phenyl)pyrazol-1-yl]-1-methyl-ethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; C19H19ClN6O2; ODM201; N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; BAY 1841788; ODM-201; Nebeqa (TN); Darolutamide (Standard); DAROLUTAMIDE [MI]; DAROLUTAMIDE [INN]; DAROLUTAMIDE [JAN]; UNII-X05U0N2RCO; ODM-201(Darolutamide)?; DAROLUTAMIDE [WHO-DD]; Darolutamide (JAN/USAN/INN); orb1300350; SCHEMBL1814935; CHEMBL4297185; SCHEMBL13733117; SCHEMBL29390245; GTPL10439; EX-A759; ODM 201; BLIJXOOIHRSQRB-PXYINDEMSA-N; BDBM309979; DAROLUTAMIDE [ORANGE BOOK]; GLXC-90544; example 56 [US9657003]; BDBM50556205; EBC-17092; HY-16985R; NSC825331; AKOS030526387; CCG-268640; CS-5174; DB12941; NSC-825331; NCGC00484078-01; NCGC00484078-03; AC-32628; AS-75032; BAY-1841788); DA-56387; FD161413; HY-16985; SY242124; S7559; T6915; D11045; US9657003, 56; F794551; BRD-A44971162-001-01-9; Q25091391; Z2512157889; N-((2S)-1-(3-(3-CHLORO-4-CYANOPHENYL)-1H-PYRAZOL- 1-YL)PROPAN-2-YL)-5-((1RS)-1-HYDROXYETHYL)-1H-PYRAZOLE- 3-CARBOXAMIDE; N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol -1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide; N-((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide; N-((S)-1-(3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-(1-hydroxy-ethyl)-1H-pyrazole-3-carboxamide; N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl]-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide; N-[(S)-1-[3-(3-Chloro-4-cyanophenyl)-1-pyrazolyl]-2-propyl]-5-(1-hydroxyethyl)pyrazole-3-carboxamideSynonymes